CN115089502A - 一种保湿精华乳及其制备方法 - Google Patents
一种保湿精华乳及其制备方法 Download PDFInfo
- Publication number
- CN115089502A CN115089502A CN202210977846.5A CN202210977846A CN115089502A CN 115089502 A CN115089502 A CN 115089502A CN 202210977846 A CN202210977846 A CN 202210977846A CN 115089502 A CN115089502 A CN 115089502A
- Authority
- CN
- China
- Prior art keywords
- essence milk
- moisturizing essence
- moisturizing
- extract
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000013336 milk Nutrition 0.000 title claims description 56
- 239000008267 milk Substances 0.000 title claims description 56
- 210000004080 milk Anatomy 0.000 title claims description 56
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 239000000686 essence Substances 0.000 claims description 53
- 239000000843 powder Substances 0.000 claims description 34
- 239000000463 material Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 25
- 239000003963 antioxidant agent Substances 0.000 claims description 24
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- 239000004480 active ingredient Substances 0.000 claims description 23
- 235000006708 antioxidants Nutrition 0.000 claims description 23
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 20
- 241000411851 herbal medicine Species 0.000 claims description 19
- 239000002131 composite material Substances 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- -1 fatty acid ester Chemical class 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 230000003750 conditioning effect Effects 0.000 claims description 12
- 230000001804 emulsifying effect Effects 0.000 claims description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 12
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 229960001631 carbomer Drugs 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 244000063299 Bacillus subtilis Species 0.000 claims description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 8
- 230000002421 anti-septic effect Effects 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- 241000133231 Marshallia caespitosa Species 0.000 claims description 6
- 244000131316 Panax pseudoginseng Species 0.000 claims description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 6
- 244000197580 Poria cocos Species 0.000 claims description 6
- 235000008599 Poria cocos Nutrition 0.000 claims description 6
- 240000003152 Rhus chinensis Species 0.000 claims description 6
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 6
- 241001506047 Tremella Species 0.000 claims description 6
- 235000010208 anthocyanin Nutrition 0.000 claims description 6
- 229930002877 anthocyanin Natural products 0.000 claims description 6
- 239000004410 anthocyanin Substances 0.000 claims description 6
- 150000004636 anthocyanins Chemical class 0.000 claims description 6
- 235000013871 bee wax Nutrition 0.000 claims description 6
- 239000012166 beeswax Substances 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 6
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 229920000223 polyglycerol Polymers 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 229940032094 squalane Drugs 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- IFUIZTXEZOJQJI-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;propane-1,2-diol Chemical compound CC(O)CO.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O IFUIZTXEZOJQJI-RXSVEWSESA-N 0.000 claims description 5
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 5
- 241000371652 Curvularia clavata Species 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- 102000016943 Muramidase Human genes 0.000 claims description 5
- 108010014251 Muramidase Proteins 0.000 claims description 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 claims description 5
- 235000019270 ammonium chloride Nutrition 0.000 claims description 5
- 239000000919 ceramic Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 229940014041 hyaluronate Drugs 0.000 claims description 5
- 235000010335 lysozyme Nutrition 0.000 claims description 5
- 239000004325 lysozyme Substances 0.000 claims description 5
- 229960000274 lysozyme Drugs 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 5
- 240000008886 Ceratonia siliqua Species 0.000 claims description 4
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 4
- 229960005150 glycerol Drugs 0.000 claims description 4
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000168525 Haematococcus Species 0.000 claims description 3
- 241000414067 Inonotus obliquus Species 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 229920002545 silicone oil Polymers 0.000 claims description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 2
- 241001290610 Abildgaardia Species 0.000 claims description 2
- 108010022355 Fibroins Proteins 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 3
- 241000722731 Carex Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 229940045547 calvatia gigantea extract Drugs 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 22
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 229910052799 carbon Inorganic materials 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 8
- 102000016387 Pancreatic elastase Human genes 0.000 description 7
- 108010067372 Pancreatic elastase Proteins 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000001153 anti-wrinkle effect Effects 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000045459 Carex meyeriana Species 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000148992 Lindera benzoin Species 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000220286 Sedum Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Insects & Arthropods (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明属于化妆品技术领域，涉及化妆品组合物，本发明公开了一种保湿精华乳及其制备方法，在本发明技术方案以精华乳基底为基础，添加天然皮肤调理活性成分、防腐活性成分和抗氧化活性成分，各种活性成分相互协同发挥增效作用，对衰老、缺少皮肤皮肤发挥显著的持久补水保湿功效的同时强健肌底、提高皮肤抗氧化、抗老化能力，具有改善皮肤暗沉、提亮肤色、紧致肌肤、抗皱抗衰老，减少肌肤皱纹的功效。
Description
技术领域
本发明涉及化妆品技术领域，涉及化妆品组合物，尤其涉及一种保湿精华乳及其制备方法。
背景技术
皮肤是维持人的生命和健康的重要器官，皱纹是当皮肤受到外界环境的影响时或因为面部的肌肉反复的运动牵拉，形成游离自由基，自由基破坏正常细胞膜组织内的胶原蛋白、活性物质，氧化细胞等而形成。随着人们生活水平的不断提高以及对健康的重视，如何减少皱纹的产生，恢复青春焕发的肤色和延缓衰老是人们十分关心的问题。
目前市场上的具有补水、抗皱以及紧致肌肤作用的美容保湿护肤品很多，多数都是化学合成的一些抗皱保湿产品，虽然可以短期内起到抗皱保湿的功效，从长远看，对皮肤又是另一种伤害。光子嫩肤等是近年来运用比较多的技术，该手段虽然在短时期内能够有立竿见影的效果，但是效果难以维持，而且治疗费用高昂，不适宜推广使用。
随着经济迅速发展，人们的消费理念发生了较大改变，其中，对护肤品的要求也越来越高，保湿、修复等理念逐渐深入人心。以中药材或其提取物为原料制备的护肤品在具备上述功效的同时还具有温和、安全、低敏等优点，深受广大消费者青睐。
发明内容
有鉴于此，针对现有技术的不足，提供了一种保湿精华乳，具有持久保湿、减少肌肤皱纹的功效，不含任何激素及有害化学物质，易吸收，长期使用能够显著抗皱、使肌肤保持水润光泽；此外，本发明还提供了上述保湿精华乳的制备方法，该方法工艺简单、原料易得，适合工业化生产。
为了达到上述目的，本发明采用如下技术方案：
一种保湿精华乳，由精华乳基底成分、抗氧化剂活性成分、皮肤调理活性成分和去离子水组成；其中，按质量百分含量计，精华乳基底成分32.9％、抗氧化剂活性成分1.77％～3.76％、皮肤调理活性成分17％～31％。
进一步，上述保湿精华乳还包括防腐活性成分，所述防腐活性成分包括以下质量百分含量的组分：0.05～0.1％茴香酸、0.013～0.016％辛酰羟肟酸。
优选的，上述保湿精华乳中，精华乳基底成分、抗氧化剂活性成分、皮肤调理活性成分、防腐活性成分和去离子水总质量百分数为100％。
优选的，所述精华乳基底成分包括以下质量百分含量的组分：8％甘油、1％1，2-己二醇、0.2％黄原胶、1％EDTA二钠、0.2％卡波姆、3.5％二甲基硅油、4.5％角鲨烷、7％橄榄油、2％辛酸/癸酸和甘油三酯、3％环五聚二甲基硅氧烷蜂蜡、1％维生素C丙二醇透明质酸酯、1.5％聚甘油脂肪酸酯。
优选的，所述抗氧化剂活性成分包括以下质量百分含量的组分：0.02～0.06％银耳多糖、0.2～0.4％盐肤木叶多酚、0.3～1.5％生育酚、0.5～0.8％黑米花青素、0.7～1％褐藻胶寡糖。
优选的，上述保湿精华乳皮肤调理活性成分包括以下质量百分含量的组分：1.5～2％角豆肽提取物、1～2％丝素肽、2～4％红球藻发酵液、3～5％桦褐孔菌提取物、2.5～4％大秃马勃提取液、5～10％中草药发酵提取液、2～4％马乳。
优选的，中草药发酵提取液制备方法为：
①按重量份计，分别将千日菊15～20份、茯苓7～15份、乌拉草8～12份、三七10～17份四种原料于粉碎机中粉碎至100目后混合制成混料，按料液比1︰20～25与水混合，放入80～90℃恒温水浴锅中加热搅拌2～3h，用细纱布过滤，得混合提取液；
②将混合提取液于121℃灭菌30min，降温至37～40℃，接入混合提取液重量6％～10％的复合菌种粉，再分别加入复合菌种粉重量5％～7％果糖和6％～8％氯化铵，置于30～37℃，转速120r/min，培养10～16h，用氢氧化钠调PH为5，加入溶菌酶反应1h，用200目纱布滤除残渣，将过滤液加入其重量的3.5％的活性炭，于80～90℃下脱色30min，滤除活性炭，收集滤液，浓缩至重量的一半；将浓缩液通过200nm的陶瓷膜精滤即得中草药发酵提取液。
优选的，复合菌种粉由枯草芽孢杆菌粉、乳酸菌粉、纳豆芽孢杆菌粉、酵母菌粉按重量比1:1:1:混合而成。
本发明还提供上述保湿精华乳的制备方法，所述制备方法包括：
ⅰ:按质量百分含量计，将卡波姆在去离子水中分散均匀后再加入甘油、1，2～己二醇、黄原胶、EDTA二钠搅拌下加热至全部溶解，得到水相混合料；
ⅱ：按质量百分含量计，将二甲基硅油、角鲨烷、橄榄油、辛酸/癸酸和甘油三酯、环五聚二甲基硅氧烷蜂蜡搅拌混匀，加入抗氧化剂活性成分、维生素C丙二醇透明质酸酯、聚甘油脂肪酸酯，搅拌下加热至全部溶解，得到油相混合料；
ⅲ：将水相混合料倒入油相混合料中，混合均匀，加入真空乳化机中，均质乳化，抽真空得到乳化料；
ⅳ：按质量百分含量计，将乳化料一次降温，加入防腐活性成分，搅拌均匀,二次降温，加入皮肤调理活性成分，搅拌均匀，静置，即得保湿精华乳。
优选的，步骤ⅰ和步骤ⅱ中，加热温度为75～90℃。
优选的，步骤ⅲ中的均质乳化温度为75～85℃，均质乳化时间为8～10min，搅拌速度为20～30r/min，真空度为-0.1～-1.0MPa。
优选的，步骤ⅳ中一次降温温度为55～65℃，二次降温温度为40～45℃，静置时间为30～60min。
经由上述的技术方案可知，与现有技术相比，本发明公开提供了一种保湿精华乳，在本发明技术方案以精华乳基底为基础，添加天然皮肤调理活性成分、防腐活性成分和抗氧化活性成分，各种活性成分相互协同发挥增效作用，对衰老、缺少皮肤皮肤发挥显著的持久补水保湿功效的同时强健肌底、提高皮肤抗氧化、抗老化能力，具有改善皮肤暗沉、提亮肤色、紧致肌肤、抗皱抗衰老，减少肌肤皱纹的功效；并且纯天然草本成分，不含任何激素及有害化学物质，安全温和无刺激，使用体验感佳，滋润而不黏腻，容易被衰老皮肤吸收，成本低，保质期长。
1、传统常规的化学合成小分子保湿护肤品虽然能给皮肤带来即时的补水和抗皱，但是却不能达到持久作用，因此需要连续使用，长期使用必然会给皮肤带来一定的伤害，本发明提供的保湿精华乳选用了纯天然的植物草本成分作为调理皮肤的活性成分，无任何刺激、对皮肤温和、低敏、能够解决皮肤缺水、皱纹的根本问题，并且达到持久效用。
2、本发明技术方案中添加了多种天然成分，如角豆肽提取物不仅促进了水通道蛋白的表达，从而调节了水分重吸收、液体分泌和细胞内外水平衡功能，有效保护了皮肤免受脱水诱导的胁迫，而且和丝素肽相互配合清除皮肤中过剩的自由基或过氧化物，减弱了皮肤中胶原网络结构的破坏，提高了皮肤的弹性，从而发挥抗皱功效，同时还加入了马乳，相比于牛乳、羊乳而言，马乳含有更加丰富的不饱和脂肪酸、能够防止自由基对皮肤细胞的伤害，防止皮肤干燥和角质化；如大秃马勃提取液，大秃马勃提取液中含有大秃马勃多糖，大秃马勃多糖有较强的清除羟基自由基、过氧化氢、DPPH自由基的能力，同时由于大秃马勃多糖是多羟基的大分子结构有利于与水分子形成氢键，从而容易从环境中吸收水分，因此具有较好的吸湿性，能够对皮肤起到很好的锁水保湿作用。
3、现有技术中的中草药花化妆品，较多直接添加中草药提取物，本发明使用的是将混合中草药提取液经过多菌种发酵的发酵提取液，添加中草药发酵提取液的优势在于，通过多菌种发酵，使得中草药中的多糖等活性成分含量增加，抗氧化、保湿性、抗衰老作用更强；而且通过发酵使得中草药中的一些大分子物质分解为小分子物质，能够更好的被肌肤吸收，同时减少肌肤过敏的发生率。
4、相比于添加传统的尼泊金酯类类的防腐成分相比，本发明添加了茴香酸和辛酰羟肟酸。茴香酸，茴香酸来源于天然物质茴香菜和茴香油，又名对茴香酸或大茴香酸，具有较好的防腐效果，辛酰羟肟酸也称辛酰氧肟酸，是有机酸的一种，对金属离子有较强的螯合能力；在茴香酸的防腐体系中，既可以帮助茴香酸更好的溶解在产品中，保持茴香酸在产品中的稳定性，又起到协同增效的作用，进一步提高了茴香酸防腐的功效。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1～3的保湿精华乳，包括质量百分含量为如表1所示组分。
表1-实施例1-实施3组分表
将表1中的配方按照以下步骤进行制备
ⅰ:按质量百分含量计，将卡波姆在去离子水中分散均匀后再加入甘油、1，2～己二醇、黄原胶、EDTA二钠搅拌下加热至全部溶解，加热温度控制75～90℃，得到水相混合料；
ⅱ：按质量百分含量计，将二甲基硅油、角鲨烷、橄榄油、辛酸/癸酸和甘油三酯、环五聚二甲基硅氧烷蜂蜡搅拌混匀，加入抗氧化剂活性成分、维生素C丙二醇透明质酸酯、聚甘油脂肪酸酯，搅拌下加热至全部溶解，加热温度控制75～90℃，得到油相混合料；
ⅲ：将水相混合料倒入油相混合料中，混合均匀，加入真空乳化机中，均质乳化，乳化温度为75～85℃，乳化时间为8～10min，搅拌速度为20～30r/min，抽真空得到乳化料，真空度为-0.1～-1.0MPa；
ⅳ：按质量百分含量计，将乳化料一次降温至55～65℃，加入防腐活性成分，搅拌均匀,二次降温至40～45℃，加入皮肤调理活性成分，搅拌均匀，静置30～60min，即得保湿精华乳。
所述表1配方中的实施例1的中草药发酵提取液制备方法为：
①按重量份计，分别将千日菊15份、茯苓7份、乌拉草8份、三七10份四种原料于粉碎机中粉碎至100目后混合制成混料，按料液比1︰20与水混合，放入80℃恒温水浴锅中加热搅拌3h，用细纱布过滤，得混合提取液；
②将混合提取液于121℃灭菌30min，降温至37℃，接入混合提取液重量6％的复合菌种粉，再分别加入复合菌种粉重量5％果糖和6％氯化铵，置于30℃，转速120r/min，培养16h，用氢氧化钠调PH为5，加入溶菌酶反应1h，用200目纱布滤除残渣；将过滤液加入其重量的3.5％的活性炭，于80℃下脱色30min，滤除活性炭，收集滤液，浓缩至重量的一半；将浓缩液通过200nm的陶瓷膜精滤即得中草药发酵提取液，其中，复合菌种粉由枯草芽孢杆菌粉、乳酸菌粉、纳豆芽孢杆菌粉、酵母菌粉按重量比1:1:1:混合而成。
所述表1配方中的实施例2的中草药发酵提取液制备方法为：
①按重量份计，分别将千日菊20份、茯苓15份、乌拉草12份、三七17份四种原料于粉碎机中粉碎至100目后混合制成混料，按料液比1︰25与水混合，放入90℃恒温水浴锅中加热搅拌2h，用细纱布过滤，得混合提取液；
②将混合提取液于121℃灭菌30min，降温至40℃，接入混合提取液重量10％的复合菌种粉，再分别加入复合菌种粉重量7％果糖和8％氯化铵，置于37℃，转速120r/min，培养16h，用氢氧化钠调PH为5，加入溶菌酶反应1h，用200目纱布滤除残渣，将过滤液加入其重量的3.5％的活性炭，于90℃下脱色30min，滤除活性炭，收集滤液，浓缩至重量的一半；将浓缩液通过200nm的陶瓷膜精滤即得中草药发酵提取液；其中，复合菌种粉由枯草芽孢杆菌粉、乳酸菌粉、纳豆芽孢杆菌粉、酵母菌粉按重量比1:1:1:混合而成。
所述表1配方中的实施例3的中草药发酵提取液制备方法为：
①按重量份计，分别将千日菊18份、茯苓10份、乌拉草10份、三七15份四种原料于粉碎机中粉碎至100目后混合制成混料，按料液比1︰22与水混合，放入85℃恒温水浴锅中加热搅拌2.5h，用细纱布过滤，得混合提取液；
②将混合提取液于121℃灭菌30min，降温至38.5℃，接入混合提取液重量8％的复合菌种粉，再分别加入复合菌种粉重量6％果糖和7％氯化铵，置于35℃，转速120r/min，培养12h，用氢氧化钠调PH为5，加入溶菌酶反应1h，用200目纱布滤除残渣，将过滤液加入其重量的3.5％的活性炭，于85℃下脱色30min，滤除活性炭，收集滤液，浓缩至重量的一半。将浓缩液通过200nm的陶瓷膜精滤即得中草药发酵提取液。
本说明书中各个实施例采用递进的方式描述，每个实施例重点说明的都是与其他实施例的不同之处，各个实施例之间相同相似部分互相参见即可。
对所公开的实施例的上述说明，使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的，本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下，在其它实施例中实现。因此，本发明将不会被限制于本文所示的这些实施例，而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
试验例1
按照实施例1、实施例2和实施例3配方以及制备方法制备的保湿精华乳产品的粘度为5000～10000Pa.S，淡中草药香味、色泽亮白、外观细腻pH值为5.5～6.5，同时按照行业标准QB/T2286进行检测，检测结果符合规定(pH在4.0～8.5范围)。检测项目如下：在～10℃、40℃及高低温交变箱中放置24h无油水分离现象。
试验例2
本试验通过考察实施例1、实施2和实施3制备的保湿精华乳对·OH和DPPH·两种自由基的清除作用，评价其抗氧化性能。测定方法依照行业标准《T～SHRH006－2018化妆品－自由基(DPPH)清除实验方法》。具体测试结果见表2。
表2-·OH和DPPH·的清除率测定结果
| 组别 | DPPH·的清除率 | ·OH的清除率 |
| 实施例1 | 80.72％ | 51.39％ |
| 实施例2 | 80.51％ | 50.46％ |
| 实施例3 | 81.29％ | 54.18％ |
从表2数据明显可知，本发明制备的保湿精华乳DPPH·的清除率和·OH的清除率分别达到了81.29％和54.18％，说明具有较好的抗氧化能力。
试验例3
本发明实施例1、实施2和实施3制备的保湿精华乳抗皱功效测定。测定方法以弹性蛋白酶抑制率表征抗皱功效；弹性蛋白酶抑制率的测定方法根据《化药部颁标准》弹性酶章节中的弹性蛋白酶活性测定方法而设计。测定结果见表3。
表3-弹性蛋白酶抑制率检测结果
| 组别 | 弹性蛋白酶抑制率 |
| 实施例1 | 15.23％ |
| 实施例2 | 15.12％％ |
| 实施例3 | 15.81％ |
弹性蛋白是维持皮肤弹性的重要蛋白，抑制弹性蛋白酶可减缓弹性蛋白流失导致的皮肤老化松弛、下垂和细纹；从表3测定的数据明显可以看出，本发明实施例制备的保湿精华乳物具有显著的弹性蛋白酶抑制作用，能够很好的发挥抗皱的功效。
试验例4
本发明实施例1、实施2和实施3制备的保湿精华乳保湿能力测定。将每个实施例分别称取2份5g样品置于直径为4cm的称量瓶中，室温下分别在相对湿度43％和75％的环境中放置8h，记录最终质量变化计算吸湿率，测定结果见表4。
吸湿率计算公式为：吸湿率＝(m8-m0)/m0×100％,式中m8为第8小时的样品质量，g；m0为试验前样品质量，g。
表4-保湿性能测定结果
从表4数据可知，吸湿率均为负值，说明本发明制备的保湿精华乳较长时间放置也会失水，但失水非常缓慢，反应出本发明制备的保湿精华乳具有较好的保湿能力，使用后能够很好的锁住皮肤的水分，让皮肤长时间保持水润性。
试验例5
按表5将抗氧化剂进行复配后用于制备保湿精华乳，标号A-1、A-2、A-3、A-4、A-5、A-6，进行抗氧化能力测试，测试结果见表6。测试方法同试验例2中一致。
表5-抗氧化剂复配表
| 抗氧化剂 | A-1 | A-2 | A-3 | A-4 | A-5 | A-6 |
| 生育酚 | 0 | 0.90％ | 0.90％ | 0.90％ | 0.90％ | 0 |
| 银耳多糖 | 0 | 0.04％ | 0.04％ | 0.04％ | 0.04％ | 0 |
| 盐肤木叶多酚 | 0 | 0 | 0.30％ | 0.30％ | 0.30％ | 0 |
| 黑米花青素 | 0 | 0 | 0 | 0.65％ | 0.65％ | 0 |
| 褐藻胶寡糖 | 0 | 0 | 0 | 0 | 0.85％ | 0 |
| 抗坏血酸 | 0 | 0 | 0 | 0 | 0 | 0.90％ |
表6-抗氧化能力测试结果
从表6数据可以看出，A-1组作为空白组，未添加任何抗氧化剂，DPPH·的清除率和·OH的清除率是6组之中最低的，分别为8.85％和6.59％。相比于A-1组,A-6组抗氧化剂选择了市售的抗坏血酸，DPPH·的清除率和·OH的清除率有所提高，分别为19.98％和10.61％，V C能促进组织中胶原蛋白的形成，在人体内还能直接将电子供给DPPH·和·OH，使它们失活，产生不活跃的自由基产物；A-2组中加入了生育酚和银耳多糖，相比于单一添加抗坏血酸，DPPH·的清除率和·OH的清除率进一步提高，生育酚能与活泼的自由基发生反应，使脂质过氧化物转化为羟脂，具有较强的自由基清除能力；银耳多糖也具有一定的抗氧化能力，分别为50.43％和40.37％；A-3组在A-2组的基础上又加入了盐肤木叶多酚，盐肤木叶多酚具有较强的抗氧化性，在生育酚的协同增效作用下，使得A-3组制备的精华乳相比A-2组，DPPH·的清除率和·OH的清除率提高到62.88％和31.62％；A-4组在A-3组的基础上，加入了黑米花青素，花青素具有良好的抗氧化活性，可以通过减少脂质氢过氧化物和丙二醛的形成抑制脂质氧化，使得DPPH·的清除率和·OH的清除率提高到73.56％％和43.58％；A-5组又加入了褐藻胶寡糖，褐藻胶寡糖具有更好的清除DPPH自由基和羟基自由基的能力，与A-4组的抗氧化剂共同构成了抗氧化网络体系，因此，使得DPPH·的清除率和·OH的清除率提高到81.29％％和54.18％。
试验例6
按照实施例1、实施例2和实施例3配方以及制备方法制备的保湿精华乳抑菌功效进行测定，测定方法依照国家卫生行业标准《W/S/T 650～2019抗菌和抑菌效果评价方法》中的5.1悬液定量抑菌试验，样品与菌悬液作用时间10min,以金黄色葡萄球菌作试验菌；菌悬液浓度4.6×106CFU/ml。测试结果见表7。
表7-抑菌功效测试结果
| 组别 | 抑菌率 |
| 实施例1 | 91.23％ |
| 实施例2 | 90.18％ |
| 实施例3 | 93.29％ |
从表7数据可知，本发明制备的保湿精华乳抑菌活性达到了90％以上，充分说明抑菌活性很强。
试验例7
本发明制备的保湿精华乳使用效果评价
1、测试人群：随机选取30名35～60岁健康女性(妊娠哺乳期除外)，无严重系统疾病、无免疫性缺陷或自身免疫性疾病者、无过敏性疾病，参与测试前1个月内未参加其他临床实验；且无活性过敏史；无炎症等皮肤病未愈者。且根据实验需求选取眼部皮肤有明显细纹及色斑等衰老现象者。
2、皮肤涂用：选取30名志愿者，取适量本发明实施例3制备的保湿精华乳轻拍在皮肤上，适当按摩，使精华乳能更好地被吸收，每天早晚各使用一次，连续用30d，使用前测试一次，1个月后测试一次。
3测试方法
①使用皮肤弹性测定仪Cutometer dual MPA580检测每次使用前后眼部的弹性指标R2，测量3次取平均值。R2值是无负压时皮肤的回弹量与有负压时的最大拉伸量比。R2值越接近1，说明皮肤弹性越好。
②使用皮肤光泽度测定探头Probe Skin-GlossymeterGL200检测每次使用前后皮肤光泽度，测量3次取平均值。光泽度值越高，说明皮肤光泽度越好。
③使用皮肤水分测定探头Probe Corneometer CM825检测每次使用前后皮肤的水分，测量10次取平均值。
4、人体测试结果
30名志愿者使用本发明实施例3制备的保湿精华乳1个月前后皮肤的弹性、光亮度、水分含量数值变化的平均值列于表8。
表8-人体测试结果
从表8测试结果可以看出，使用本发明制备的保湿精华乳后，皮肤弹性、光泽度、水分含量的评分均值都有一定增长。其中弹性数值R2增加了0.215，肤色光泽度增加了1.18，水分含量增加了11.7％。充分体现了本发明制备的保湿精华乳在较短时间内可以改善皮肤暗沉、增加皮肤含水量以及皮肤弹性，说明本发明制备的精华乳保湿效果和抗皱效果好，对皮肤能够起到很好的紧致作用。
Claims (10)
1.一种保湿精华乳，其特征在于，所述保湿精华乳包括以下组分：精华乳基底成分、抗氧化剂活性成分、皮肤调理活性成分和去离子水；所述精华乳基底成分包括以下组分：甘油、1，2-己二醇、黄原胶、EDTA二钠、卡波姆、二甲基硅油、角鲨烷、橄榄油、辛酸/癸酸和甘油三酯、环五聚二甲基硅氧烷蜂蜡、维生素C丙二醇透明质酸酯、聚甘油脂肪酸酯；所述抗氧化剂活性成分包括以下组分：银耳多糖、盐肤木叶多酚、生育酚、黑米花青素和褐藻胶寡糖；所述皮肤调理活性成分包括以下组分：角豆肽提取物、丝素肽、红球藻发酵液、桦褐孔菌提取物、大秃马勃提取液、中草药发酵提取液、马乳。
2.根据权利要求1所述的一种保湿精华乳，其特征在于，按质量百分含量计，所述精华乳由32.9％精华乳基底成分、1.77％～3.76％抗氧化剂活性成分、17％～31％皮肤调理活性成分和去离子水组成；
所述精华乳基底成分包括以下组分：8％甘油、1％1，2-己二醇、0.2％黄原胶、1％EDTA二钠、0.2％卡波姆、3.5％二甲基硅油、4.5％角鲨烷、7％橄榄油、2％辛酸/癸酸和甘油三酯、3％环五聚二甲基硅氧烷蜂蜡、1％维生素C丙二醇透明质酸酯、1.5％聚甘油脂肪酸酯；
所述抗氧化剂活性成分包括以下质量百分含量组分：0.02～0.06％银耳多糖、0.2～0.4％盐肤木叶多酚、0.3～1.5％生育酚和0.5～0.8％黑米花青素、褐藻胶寡糖0.7～1％；
所述皮肤调理活性成分包括以下质量百分含量组分：1.5～2％角豆肽提取物、1～2％丝素肽、2～4％红球藻发酵液、3～5％桦褐孔菌提取物、2.5～4％大秃马勃提取液、5～10％中草药发酵提取液、2～4％马乳。
3.根据权利要求1或2所述的一种保湿精华乳，其特征在于，还包括防腐活性成分，所述防腐活性成包括以下质量百分含量的组分：0.05～0.1％茴香酸、0.013～0.016％辛酰羟肟酸。
4.根据权利要求1或2所述的一种保湿精华乳，其特征在于，中草药发酵提取液制备方法为：
①分别将千日菊、茯苓、乌拉草和三七四种原料于粉碎机中粉碎至100目后混合制成混料，按料液比1︰20～25与水混合，放入80～90℃恒温水浴锅中加热搅拌2～3h，用细纱布过滤，得混合提取液；
②将混合提取液于121℃灭菌30min，降温至37～40℃，接入混合提取液重量6％～10％的复合菌种粉，再分别加入复合菌种粉重量5％～7％果糖和6％～8％氯化铵，置于30～37℃，转速120r/min，培养10～16h，用氢氧化钠调PH为5，加入溶菌酶反应1h，用200目纱布滤除残渣；将过滤液加入其重量的3.5％的活性炭，于80～90℃下脱色30min，滤除活性炭，收集滤液，浓缩至重量的一半；将浓缩液通过200nm的陶瓷膜精滤即得中草药发酵提取液。
5.根据权利要求4所述的一种保湿精华乳，其特征在于：复合菌种粉由枯草芽孢杆菌粉、乳酸菌粉、纳豆芽孢杆菌粉、酵母菌粉按重量比1:1:1:混合而成。
6.根据权利要求4所述的一种保湿精华乳，其特征在于：按重量份计，千日菊15～20份、茯苓7～15份、乌拉草8～12份、三七10～17份。
7.一种根据权利要求1～6任一所述的保湿精华乳的制备方法，其特征在于，包括以下步骤：
ⅰ:按质量百分含量计，将卡波姆在去离子水中分散均匀后再加入甘油、1，2-己二醇、黄原胶、EDTA二钠搅拌下加热至全部溶解，得到水相混合料；
ⅱ：按质量百分含量计，将二甲基硅油、角鲨烷、橄榄油、辛酸/癸酸和甘油三酯、环五聚二甲基硅氧烷蜂蜡搅拌混匀，加入抗氧化剂活性成分、维生素C丙二醇透明质酸酯、聚甘油脂肪酸酯，搅拌下加热至全部溶解，得到油相混合料；
ⅲ：将水相混合料倒入油相混合料中，混合均匀，加入真空乳化机中，均质乳化，抽真空得到乳化料；
ⅳ：按质量百分含量计，将乳化料一次降温，加入防腐活性成分，搅拌均匀,二次降温，加入皮肤调理活性成分，搅拌均匀，静置，即得保湿精华乳。
8.根据权利要求7所述的保湿精华乳的制备方法，其特征在于，步骤ⅰ和步骤ⅱ中，加热温度为75～90℃。
9.根据权利要求7所述的保湿精华乳的制备方法，其特征在于，步骤ⅲ中的均质乳化温度为75～85℃，均质乳化时间为8～10min，搅拌速度为20～30r/min，真空度为-0.1～-1.0MPa。
10.根据权利要求7所述的保湿精华乳的制备方法，其特征在于，步骤ⅳ中一次降温温度为55～65℃，二次降温温度为40～45℃，静置时间为30～60min。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210977846.5A CN115089502A (zh) | 2022-08-15 | 2022-08-15 | 一种保湿精华乳及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210977846.5A CN115089502A (zh) | 2022-08-15 | 2022-08-15 | 一种保湿精华乳及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115089502A true CN115089502A (zh) | 2022-09-23 |
Family
ID=83301202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210977846.5A Pending CN115089502A (zh) | 2022-08-15 | 2022-08-15 | 一种保湿精华乳及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115089502A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107362084A (zh) * | 2017-07-28 | 2017-11-21 | 张家界久瑞健康产业发展有限公司 | 一种含有盐肤木叶提取物的面膜及其制备方法 |
| CN107456424A (zh) * | 2017-08-14 | 2017-12-12 | 刘富岗 | 一种含有天然成分提取物的纳米乳精华液及其制备方法 |
| CN110051614A (zh) * | 2019-05-27 | 2019-07-26 | 贝德氏（上海）健康科技股份有限公司 | 一种抗皱嫩肤精华 |
| CN112494361A (zh) * | 2020-12-28 | 2021-03-16 | 青岛博智汇力生物科技有限公司 | 一种抑菌抗辐射的海洋寡糖隔离乳及其制备方法 |
-
2022
- 2022-08-15 CN CN202210977846.5A patent/CN115089502A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107362084A (zh) * | 2017-07-28 | 2017-11-21 | 张家界久瑞健康产业发展有限公司 | 一种含有盐肤木叶提取物的面膜及其制备方法 |
| CN107456424A (zh) * | 2017-08-14 | 2017-12-12 | 刘富岗 | 一种含有天然成分提取物的纳米乳精华液及其制备方法 |
| CN110051614A (zh) * | 2019-05-27 | 2019-07-26 | 贝德氏（上海）健康科技股份有限公司 | 一种抗皱嫩肤精华 |
| CN112494361A (zh) * | 2020-12-28 | 2021-03-16 | 青岛博智汇力生物科技有限公司 | 一种抑菌抗辐射的海洋寡糖隔离乳及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 于甜甜等: "新型原料维生素C丙二醇透明质酸酯的功效研究", 《日用化学品科学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108379140B (zh) | 一种具有美白抗衰老功能的组合物及其制备方法 | |
| US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
| CN111956591B (zh) | 一种抗敏舒缓和改善肤色的化妆品组合物及其制备方法 | |
| JP4425163B2 (ja) | 抗老化化粧料 | |
| JP2017214349A (ja) | 化粧料及び経口組成物 | |
| JP2000128765A (ja) | 皮膚化粧料 | |
| KR20190071883A (ko) | 빌베리열매의 미생물 발효를 통한 저분자 펩타이드를 함유하는 피부 보호 및 주름 개선용 화장료 조성물 | |
| KR101474340B1 (ko) | 생약 발효 추출물을 포함하는 피부 노화 방지 화장료조성물 | |
| CN112773761B (zh) | 一种化妆品组合物、精华液及其制备方法 | |
| CN114099393A (zh) | 一种具有紧致与抗衰功效的组合物及其制备方法和应用 | |
| US20170196797A1 (en) | Composition containing glycine gracilis oil | |
| CN110974775A (zh) | 一种含葛仙米的舒敏组合物及其制备方法和应用 | |
| KR101854444B1 (ko) | 아티초크잎 추출물을 유효성분으로 포함하는 튼살 예방 및 개선용 화장료 조성물 | |
| KR102308756B1 (ko) | 귤껍질 및 칼메그의 혼합추출물을 유효성분으로 함유하는 화장료 조성물 | |
| KR101775485B1 (ko) | 계혈등 발효 추출물을 유효성분으로 함유하는 화장료 조성물 | |
| CN115414289A (zh) | 虫草花化妆品及其制备方法 | |
| CN115089502A (zh) | 一种保湿精华乳及其制备方法 | |
| KR20180082058A (ko) | 천연 복합 추출물을 유효성분으로 포함하는 각질 박리용 화장료 조성물 | |
| KR20010000390A (ko) | 김치추출물을 함유하는 노화 및 여드름을 포함한피부개선제 혼합조성물 | |
| CN113855604A (zh) | 一种植物萃取的瑶音植萃精华液及使用方法 | |
| KR20110122448A (ko) | 지리터리풀 추출물을 유효성분으로 함유하는 화장료 조성물 | |
| US20190224259A1 (en) | Fermentation product of punica granatum and uses thereof | |
| KR102465293B1 (ko) | 술지게미 발효추출물의 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
| KR102335682B1 (ko) | 에퀴세툼 기간테움 발효추출물을 유효성분으로 함유하는 피부 보습용 화장료 조성물 | |
| CN115364036B (zh) | 一种含有蜗牛发酵滤液的组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220923 |
|
| RJ01 | Rejection of invention patent application after publication |